Association of NALP2 polymorphism with arsenic induced skin lesions and other health effects

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 755, Issue 1, 2013, Pages 1-5

  Bhattacharjee, Pritha ^a   Das, Nandana ^a   Chatterjee, Debmita ^a   Banerjee, Anirban ^a   Das, Jayanta K ^b   Basu, Santanu ^c   Banerjee, Saptarshi ^d   Majumder, Papia ^e   Goswami, Prashant ^f   Giri, Ashok K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b West Bank Hospital   (India)

^c Sri Aurobindo Seva Kendra ^*  (India)

^d MEDICAL COLLEGE AND HOSPITAL   (India)

^e Manipal Tata Medical College Jamshedpur   (India)

^f CSIR Centre for Mathematical Modelling and Computer Simulation   (India)

Author keywords

Arsenic; Chromosomal aberration; NALP2 polymorphism; Respiratory disease; Skin lesion

Indexed keywords

ARSENIC;

ADULT; ALLELE; ARSENIC POISONING; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; EXON; EYE DISEASE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN CELL; INDIA; MAJOR CLINICAL STUDY; MALE; NALP2 GENE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN TOXICITY;

ARSENIC; CHROMOSOMAL ABERRATION; NALP2 POLYMORPHISM; RESPIRATORY DISEASE; SKIN LESION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ARSENIC; ARSENIC POISONING; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; EYE DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; SKIN DISEASES;

ANIMALIA;

EID: 84880043659     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2013.04.010     Document Type: Article

References (35)

1. WHO Guidelines for Drinking Water Quality, Health Criteria and Other Supporting Information 1996, vol. 2:940-994. WHO, Geneva. 2nd ed.
2. Ghosh P., Banerjee M., De Chaudhuri S., Das J.K., Sarma N., Basu A., Giri A.K. Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic. Mutat. Res. 2007, 632:104-110.
3. Banerjee M., Bhattacharjee P., Giri A.K. Arsenic-induced cancers: a review with special reference to gene, environment and their interactions. Genes Env. 2011, 33:128-140.
4. Ghosh P., Banerjee M., De Chaudhuri S., Chowdhury R., Das J.K., Mukherjee A., Sarkar A.K., Mondal L., Baidya K., Sau T.J., Banerjee A., Basu A., Chaudhuri K., Ray K., Giri A.K. Comparison of health effects between individuals with and without skin lesions in the population exposed to arsenic through drinking water in West Bengal, India. J. Expo. Sci. Environ. Epidemiol. 2007, 17:215-223.
5. Kitchin K.T. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 2001, 172:249-261.
6. Tseng C.H. The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol. Appl. Pharmacol. 2004, 197:67-83.
7. Applebaum K.M., Karagas M.R., Hunter D.J., Catalano P.J., Byler S.H., Morris S., Nelson H.H. Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire. Environ. Health Perspect. 2007, 115:1231-1236.
8. Buckman S.Y., Gresham A., Hale P., Hruza G., Anast J., Masferrer J., Pentland A.P. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 1998, 19:723-729.
9. Moore R.J., Owens D.M., Stamp G., Arnott C., Burke F., East N., Holdsworth H., Turner L., Rollins B., Pasparakis M., Kollias G., Balkwill F. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat. Med. 1999, 5:828-831.
10. Chan K.S., Sano S., Kiguchi K., Anders J., Komazawa N., Takeda J., DiGiovanni J. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J. Clin. Invest. 2004, 114:720-728.
11. Lind M.H., Rozell B., Wallin R.P., van Hogerlinden M., Ljunggren H.G., Toftgård R., Sur I. Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4972-4977.
12. Banerjee N., Banerjee S., Sen R., Bandyopadhyay A., Sarma N., Majumder P., Das J.K., Chatterjee M., Kabir S.N., Giri A.K. Chronic arsenic exposure impairs macrophage functions in the exposed individuals. J. Clin. Immunol. 2009, 29:582-594.
13. Church L.D., Cook G.P., McDermott M.F. Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat. Clin. Pract. Rheumatol. 2008, 4:34-42.
14. Martinon F., Gaide O., Pétrilli V., Mayor A., Tschopp J. NALP inflammasomes: a central role in innate immunity. Semin. Immunopathol. 2007, 29:213-229.
15. Srikrishna G., Freeze H.H. Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 2009, 11:615-628.
16. Tschopp J., Martinon F., Burns K. NALPs: a novel protein family involved in inflammation. Nat. Rev. Mol. Cell Biol. 2003, 4:95-104.
17. Magitta N.F., Bøe Wolff A.S., Johansson S., Skinningsrud B., Lie B.A., Myhr K.M., Undlien D.E., Joner G., Njølstad P.R., Kvien T.K., Førre Ø., Knappskog P.M., Husebye E.S. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun. 2009, 10:120-124.
18. Jin Y., Birlea S.A., Fain P.R., Spritz R.A. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J. Invest. Dermatol. 2007, 127:2558-2562.
19. Rosengren S., Hoffman H.M., Bugbee W., Boyle D.L. Expression and regulation of cryopyrin and related proteins in rheumatoid arthritis synovium. Ann. Rheum. Dis. 2005, 64:708-714.
20. Alimohammadi M., Björklund P., Hallgren A., Pöntynen N., Szinnai G., Shikama N., Keller M.P., Ekwall O., Kinkel S.A., Husebye E.S., Gustafsson J., Rorsman F., Peltonen L., Betterle C., Perheentupa J., Akerström G., Westin G., Scott H.S., Holländer G.A., Kämpe O. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N. Engl. J. Med. 2008, 358:1018-1028.
21. Bruey J.M., Bruey-Sedano N., Newman R., Chandler S., Stehlik C., Reed J.C. PAN1/NALP2/PYPAF2 an inducible inflammatory mediator that regulates NF-Kβ and Caspase-1 activation in macrophages. J. Biol. Chem. 2004, 279:51897-51907.
22. Agostini L., Martinon F., Burns K., McDermott M.F., Hawkins P.N., Tschopp J. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle Wells autoinflammatory disorder. Immunity 2004, 20:319-325.
23. Lamkanfi M., Kanneganti T.D., Franchi L., Núñez G. Caspase-1 inflammasomes in infection and inflammation. J. Leukoc. Biol. 2007, 82:220-225.
24. Ghosh P., Basu A., Mahata J., Basu S., Sengupta M., Das J.K., Mukherjee A., Sarkar A.K., Mondal L., Ray K., Giri A.K. Cytogenetic damage and genetic variants in the individuals susceptible to arsenic-induced cancer through drinking water. Int. J. Cancer 2006, 118:2470-2478.
25. De Chaudhuri S., Mahata J., Das J.K., Mukherjee A., Ghosh P., Sau T.J., Mondal L., Basu S., Giri A.K., Roychoudhury S. Association of specific p53 polymorphisms with keratosis in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat. Res. 2006, 601:102-112.
26. De Chaudhuri S., Ghosh P., Sarma N., Majumdar P., Sau T.J., Basu S., Roychoudhury S., Ray K., Giri A.K. Genetic variants associated with arsenic susceptibility: study of purine nucleoside phosphorylase, arsenic (+3) methyltransferase, and glutathione S-transferase omega genes. Environ. Health Perspect. 2008, 116:501-505.
27. Banerjee M., Sarkar J., Das J.K., Mukherjee A., Sarkar A.K., Mondal L., Giri A.K. Polymorphism in the ERCC2 codon 751 is associated with arsenic-induced premalignant hyperkeratosis and significant chromosome aberrations. Carcinogenesis 2007, 28:672-676.
28. Kundu M., Ghosh P., Mitra S., Das J.K., Sau T.J., Banerjee S., States J.C., Giri A.K. Precancerous and non-cancer disease endpoints of chronic arsenic exposure: the level of chromosomal damage and XRCC3 T241M polymorphism. Mutat. Res. 2011, 706:7-12.
29. Buchet J.P., Lauwerys R., Roels H. Comparison of the urinary excretion of arsenic metabolites after a single dose of sodium arsenite, monomethylarsonate or dimethylarsinate in man. Int. Arch. Occup. Environ. Health 1981, 48:71-79.
30. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 2nd ed.
31. Mahata J., Basu A., Ghoshal S., Sarkar J.N., Roy A.K., Poddar G., Nandy A.K., Banerjee A., Ray K., Natarajan A.T., Nilsson R., Giri A.K. Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat. Res. 2003, 34:133-143.
32. Rasmussen R.E., Menzel D.B. Variation in arsenic-induced sister chromatid exchange in human lymphocytes and lymphoblastoid cell lines. Mutat. Res. 1997, 386:299-306.
33. Church L.D., Churchman S.M., Hawkins P.N., McDermott M.F. Hereditary auto-inflammatory disorders and biologics. Springer Semin. Immunopathol. 2006, 27:494-508.
34. Masters S.L., Lobito A.A., Chae J., Kastner D.L. Recent advances in the molecular pathogenesis of hereditary recurrent fevers. Curr. Opin. Allergy Clin. Immunol. 2006, 6:428-433.
35. Sevenoaks M.J., Stockley R.A. Chronic obstructive pulmonary disease, inflammation and co-morbidity - a common inflammatory phenotype?. Respir. Res. 2006, 7:70.